# Kiniksa Pharmaceuticals International, plc (KNSA) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $77M |
| 2024 | -$46M |
| 2023 | -$25M |
| 2022 | $10M |
| 2021 | -$157M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $29M |
| 2025-09-30 | $24M |
| 2025-06-30 | $20M |
| 2025-03-31 | $13M |
| 2024-09-30 | -$10M |
| 2024-06-30 | -$117,000 |
| 2024-03-31 | -$17M |
| 2023-09-30 | -$11M |
| 2023-06-30 | -$3M |
| 2023-03-31 | -$11M |
| 2022-09-30 | $46M |
| 2022-06-30 | -$19M |
| 2022-03-31 | -$23M |
| 2021-09-30 | -$31M |
| 2021-06-30 | -$41M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/KNSA/operating-income)